Impact of blood salvage during liver transplantation on reduction in transfusion requirements

Acta Cirurgica Brasileira

Volumn 21, Issue SUPPL.1, 2006, Pages 44-47

  Sankarankutty, Ajith Kumar ^a,b   Teixeira, Andreza Correa ^a   Souza, Fernanda Fernandes ^a   Mente, Enio David ^b   De Oliveira, Gustavo Ribeiro ^b   Almeida, Rachel Cristina Camargo ^b   De Andrade, Camila Marques ^b   Origuella, Eliana Aparecida Lopes ^b   De Castro E Silva Jr , Orlando ^a,b,c  

^a Division of Gastroenterology   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Rua Campos Sales   (Brazil)

Author keywords

Blood Transfusion; Cell Saver; Liver Surgery; Liver Transplantation

Indexed keywords

ADULT; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; CADAVER DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE;

EID: 33749614933     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502006000700011     Document Type: Article

References (11)

1. Phillips SD, Deshpande R, Muiesan P, Bowles MJ, Rela M, Heaton ND. A Prospective Study Investigating the Cost Effectiveness of Intraoperative Blood Salvage during Liver Transplantation. Transplantation. 2006; 81:536-40.
2. Cacciarelli TV, Keeffe EB, Moore DH, Cox KL, Berquist WE, Concepcion W, Hammer GB, So SK. Effect of Intraoperative Blood Transfusion on Patient Outcome in Liver Transplantation. Arch Surg. 1999; 134:25-9.
3. Ickx BE, Van der Linden PJ, Melot C, Wijns W, de Pauw L, Vandestadt J, Hut F, Pradier O. Comparison of the Effects of Aprotinin and Tranexamic Acid on Blood Loss and Red Blood Cell transfusion Requirements during the Late Stages of Liver Transplantation. Transfusion. 2006;46:595-605.
4. Muscari F, Suc B, Vigouroux D, Duffas JP, Migueres I, Mathieu A, Lavayssiere L, Rostaing L, Fourtanier G. Blood Salvage Autotransfusion during Transplantation for Hepatocarcinoma: does it increase the risk of neoplastic recurrence? Transplant Int. 2005; 18:1236-9.
5. Siemionow MAG. Role of Blood Transfusion in Transplantation: a Review. J Reconst Microsurg. 2005; 21:555-63.
6. Chamberland ME. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? Clin Inf Dis. 2002; 34:797-805.
7. Kalicinski P, Markiewicz M, Kaminski A, Laniewski P, Ismail H, Drewniak T, Szymczak M, Nachulewicz P, Jezierska E. Single pretransplant bolus of recombinant activated factor VII ameliorates influence of risk factors for blood loss during orthotopic liver transplantation. Ped Transpl. 2005;9:299-304.
8. Niemann CU, Behrends M, Quan D, Eilers H, Gropper MA, Roberts JP, Hirose R. Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores. Transf Med. 2006; 16:93-100.
9. Lentschener C, Roche K, Ozier Y. A review of aprotinin in orthotopic liver transplantation: can its harmful effects offset its beneficial effects? Anesth Analg. 2005; 100:1248-55.
10. Sorensen ER, Lorme TB, Heath D. Thromboelastography: a means to transfusion reduction. Nurs Manage. 2005; 36:27-34.
11. Detry O, Roover AD, Delwaide J, Kaba A, Joris J, Damas P, Lamy M, Honoré P, Meurisse M. Liver Transplantation in Jehovah's Witness. Transplant Int. 2005; 18:929-36.